Tag Archives: Alzheimer’s risk

Glucose Levels at Age 35 Associated with Alzheimer’s – BUSM

Living your best life at 35, ignoring cholesterol and glucose levels, may impact your chances of getting Alzheimer’s disease (AD) later in life. According to Boston University School of Medicine (BUSM) researchers, lower HDL (high-density cholesterol) and high triglyceride levels measured in blood as early as age 35 are associated with a higher incidence of AD several decades later in life. They also found that high blood glucose measured between ages 51-60 is associated with risk of AD in the future.

Photo by MART PRODUCTION on Pexels.com

“While our findings confirm other studies that linked cholesterol and glucose levels measured in blood with future risk of Alzheimer’s disease, we have shown for the first time that these associations extend much earlier in life than previously thought,” explains senior author Lindsay A. Farrer, PhD, chief of biomedical genetics.

The researchers believe that although high LDL has been consistently associated with AD risk in many previous studies, the link between HDL and AD was inconclusive, perhaps because most studies examining these relationships were conducted in persons who were 55 years and older at baseline. 

This study was conducted using data obtained from participants of the Framingham Heart Study who were examined in approximately four-year intervals throughout most of their adult lives. Correlations of AD with multiple known risk factors for cardiovascular disease and diabetes (including HDL, LDL, triglycerides, glucose, blood pressure, smoking, and body mass index) were measured at each exam and during three age periods during adulthood (35-50, 51-60, 61-70).

The researchers found that lower HDL (the good cholesterol) is predictive of AD in early (35-50 years) and middle (51-60 years) adulthood and that high glucose in the blood (a precursor of diabetes) during mid-adulthood is also predictive of AD “These findings show for the first time that cardiovascular risk factors, including HDL which has not been consistently reported as a strong risk factor for AD, contribute to future risk of AD starting as early as age 35,” says first and corresponding author Xiaoling Zhang, MD, PhD, assistant professor of medicine.

According to the researchers, careful management of these factors starting in early adulthood can lower one’s risk of cardiovascular disease and diabetes, as well as Alzheimer’s. “Intervention targeting cholesterol and glucose management starting in early adulthood can help maximize cognitive health in later life,” adds Farrer.

Farrer also points out, “the unique design and mission of the Framingham Heart Study, which is a multi-generation, community-based, prospective study of health that began in 1948, allowed us to link Alzheimer’s to risk factors for heart disease and diabetes measured much earlier in life than possible in most other studies of cognitive decline and dementia.”

Leave a comment

Filed under Uncategorized

If a Family Member Has Alzheimer’s Disease, Will I Have It, Too? – NIH

If you are asking this question, I share your concern. My family has five cases of Alzheimer’s/dementia on both sides, including a grandparent, a parent, two aunts and a cousin.

Learning about your family health history may help you know if you are at increased risk for certain diseases or medical conditions, like Alzheimer’s disease.

Leave a comment

Filed under Uncategorized

Blood test can predict presence of beta-amyloid in the brain

Scientists have demonstrated that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain, according to a new study funded in part by NIA. Published in Neurology, the study analyzed the ability of a blood test to predict the presence of Alzheimer’s disease-associated protein beta-amyloid in the brain. The new blood test, which performs comparably to existing brain scan- or spinal tap-based tests, could lower costs and expand the availability of diagnostic studies for Alzheimer’s disease.

Photo by cottonbro on Pexels.com

Alzheimer’s is characterized by the buildup of a protein called beta-amyloid, which forms sticky plaques on the brain and can cause brain cells to die. Testing for the presence of these amyloid plaques on the brain is an important part of Alzheimer’s diagnosis and research. For people experiencing memory problems, checking for amyloid in the brain helps health care providers determine whether Alzheimer’s is the potential cause. It also can help doctors determine which patients will respond to drugs that target amyloid. For people without any signs of dementia, the presence of amyloid plaques on the brain may help researchers enroll participants in clinical trials for treatments to prevent or delay the onset of cognitive symptoms.

Leave a comment

Filed under Uncategorized

Cataract surgery may lower dementia risk

  • An observational study of more than 3,000 adults aged 65 years or older has uncovered a link between cataract surgery and a reduced risk of developing dementia, including Alzheimer’s disease.
  • The researchers say the results support the connection between sensory impairments, such as vision loss, and a higher risk for dementia.
  • The scientists also believe there is a link between blue light and the development of dementia.

More than 55 million peopleTrusted Source worldwide live with dementia — a syndrome that causes a decline in cognitive functions such as memory, language, and comprehension.

Photo by Victor Freitas on Pexels.com

Alzheimer’s disease is the most common form of dementia, accounting for 60–80% of all people who have dementia. Scientists have carried out much research over the years examining the causes of Alzheimer’s; however, they remain unclear.

Researchers from the University of Washington School of Medicine in Seattle now say they have uncovered a link between cataract surgery and a lowered risk for developing dementia in older adults, including Alzheimer’s disease.

1 Comment

Filed under Uncategorized

Greater Exposure to Estrogen May Protect Women’s Brain Regions Vulnerable to Alzheimer’s

The drop in estrogen levels that occurs with menopause brings declines in the volumes of “gray matter,” the cellular matter of the brain, in key brain regions that are also affected in Alzheimer’s disease. But a new study from Weill Cornell Medicine researchers, in collaboration with the University of Arizona, suggests that greater cumulative exposure to estrogen in life, for example from having had more children or from having taken menopause hormone therapy, may counter this brain-shrinking effect.

Photo by Anna Shvets on Pexels.com

The findings, reported Nov. 3 in Neurology, come from an analysis of personal histories, MRI scans and cognitive tests on 99 women in their late 40s to late 50s. The researchers confirmed an earlier finding linking menopause to lower gray matter volume (GMV) in brain areas that are vulnerable to Alzheimer’s. But they also linked indicators of higher overall estrogen exposure, such as a longer span of reproductive years (menarche to menopause), more children and the use of menopause hormone therapy and hormonal contraceptives, to higher GMV in some of these brain areas.

Leave a comment

Filed under aging brain, Alzheimer's disease, Alzheimer's risk, brain function, brain health, estrogen

What Are the Signs and Symptoms of Alzheimer’s?

Memory problems are often one of the first signs of Alzheimer’s. Symptoms vary from person to person, and may include problems with:

  • Word-finding, or having more trouble coming up with words than other people the same age.
  • Vision and spatial issues, like awareness of the space around them.
  • Impaired reasoning or judgment, which can impact decisions.

Other symptoms may be changes in the person’s behavior, including:

  • Taking longer to complete normal daily tasks.
  • Repeating questions.
  • Trouble handling money and paying bills.
  • Wandering and getting lost.
  • Losing things or misplacing them in odd places.
  • Mood and personality changes.
  • Increased anxiety and/or aggression.

How Is Alzheimer’s Diagnosed and Treated?

Leave a comment

Filed under Uncategorized

What Is Alzheimer’s Disease?

As a senior citizen one of my most serious concerns is my mental functioning. My mother and her sister were afflicted with forms of dementia, including Alzheimer’s Disease. Also, my father’s father suffered cognitive problems in the 1940’s. Finally, my father’s sister and her daughter, my cousin had forms of dementia. It runs in my family and judging by the number of cases reported, there is a chance it runs in yours, too.

Here is what Alzheimers.gov has to say on the subject:

Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. People with Alzheimer’s also experience changes in behavior and personality.

More than 6 million Americans, many of them age 65 and older, are estimated to have Alzheimer’s disease. That’s more individuals living with Alzheimer’s disease than the population of a large American city. Many more people experience Alzheimer’s in their lives as family members and friends of those with the disease.

The symptoms of Alzheimer’s disease — changes in thinking, remembering, reasoning, and behavior — are known as dementia. That’s why Alzheimer’s is sometimes referred to as “dementia.” Other diseases and conditions can also cause dementia, with Alzheimer’s being the most common cause of dementia in older adults.

Alzheimer’s disease is not a normal part of aging. It’s the result of complex changes in the brain that start years before symptoms appear and lead to the loss of brain cells and their connections.

What Causes Alzheimer’s?

The causes of Alzheimer’s disease are not yet fully understood, but probably include a combination of:

  • Age-related changes in the brain, like shrinking, inflammation, blood vessel damage, and breakdown of energy within cells, which may harm neurons and affect other brain cells.
  • Changes or differences in genes, which may be passed down by a family member. Both types of Alzheimer’s — the very rare early-onset type occurring between age 30 and mid-60s, and the most common late-onset type occurring after a person’s mid-60s — can be related to a person’s genes in some way. Many people with Down syndrome, a genetic condition, will develop Alzheimer’s as they age and may begin to show symptoms in their 40s.
  • Health, environmental, and lifestyle factors that may play a role, such as exposure to pollutants, heart disease, stroke, high blood pressure, diabetes, and obesity.

3 Comments

Filed under Uncategorized

Scientists Develop Detection of Alzheimer’s Disease Blood Test

An international research team led by Hong Kong University of Science and Technology (HKUST) has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer’s disease (AD) for the first time, with an accuracy level of over 96%.

Currently, doctors mainly rely on cognitive tests to diagnose a person with AD. Besides clinical assessment, brain imaging and lumbar puncture are the two most commonly used medical procedures to detect changes in the brain caused by AD. However, these methods are expensive, invasive, and frequently unavailable in many countries. 

The research team identified 19 plasma hub proteins (indicated as yellow dots in the figure) in AD patients, which are irregular compared to healthy people.

Now, a team led by Prof. Nancy IP, Vice-President for Research and Development at HKUST, has identified 19 out of the 429 plasma proteins associated with AD to form a biomarker panel representative of an “AD signature” in the blood.  Based on this panel, the team has developed a scoring system that distinguishes AD patients from healthy people with more than 96% accuracy. This system can also differentiate among the early, intermediate, and late stages of AD, and can be used to monitor the progression of the disease over time. These exciting findings have led to the development of a high-performance, blood-based test for AD, and may also pave the way to novel therapeutic treatments for the disease.

Leave a comment

Filed under Uncategorized

Healthy choices may reduce Alzheimer’s risk

No effective treatment for Alzheimer’s disease exists, even though more than 5 million Americans have it, according to the Penn State Health News.

But what if there was a way to reduce the risk? Research suggests there may be methods to protect yourself.

Photo by MART PRODUCTION on Pexels.com

What is Alzheimer’s disease?

“Alzheimer’s is the most common form of dementia,” said Dr. Chen Zhao, a neurologist at Penn State Health Milton S. Hershey Medical Center. “With Alzheimer’s, an abnormal protein builds up in the brain, and over time, that spreads to other parts of the brain and normal brain cells start to die.”

This progression can lead to problems that affect one’s day-to-day life, including short-term memory loss, getting lost, spatial and navigation issues and trouble making judgments. It can eventually lead to trouble speaking or recognizing people.

Leave a comment

Filed under Uncategorized

Neighborhood Noise May Increase Dementia Risk

Alzheimer’s disease and other forms of dementia affect millions of older adults in the US—but not equally. Past research has identified risk factors including genes, education, racism, and air pollution, and a growing number of studies now point to noise as another influence on risk of dementia.

Now, a new study co-led by a School of Public Health researcher finds that 10 decibels more daytime neighborhood noise is associated with 36 percent higher odds of mild cognitive impairment and 30 percent higher odds of Alzheimer’s disease.

Photo by Pixabay on Pexels.com

Published in Alzheimer’s & Dementia, the journal of the Alzheimer’s Association, the study is the first of its kind in the US.

“We remain in early stages in researching noise and dementia, but the signals so far, including those from our study, suggest we should pay more attention to the possibility that noise affects cognitive risk as we age,” says study first author Jennifer Weuve, associate professor of epidemiology.

4 Comments

Filed under Uncategorized

App predicts risk of developing Alzheimer’s

A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual’s risk of developing Alzheimer’s disease. Using a model that combines the levels of two specific proteins in the blood of those with mild memory impairment, the researchers are able to predict the risk of developing Alzheimer’s. The researchers have also developed an app that doctors can use to give patients a risk assessment.

Oskar Hansson and his colleagues have been researching different biomarkers for a long time to produce better diagnostics at an early stage of Alzheimer’s disease. Over the past year, they have also developed accurate markers in blood tests for Alzheimer’s. The aim has been to identify the disease at an early stage of its progression, before the actual dementia stage, in order to begin treatment to ease symptoms, avoid unnecessary examinations and create a sense of security among patients.

Leave a comment

Filed under Uncategorized

Coming soon – A simple blood test for diagnosing Alzheimer’s disease

By now I think everybody reading this blog knows about my family’s connection to Alzheimer’s and dementia. So,it should come as no surprise that I am thrilled to pass on this latest info from the Alzheimer’s Prevention Registry.

Photo by David Cassolato on Pexels.com

A promising new blood test for Alzheimer’s disease is now on the horizon.  The newly reported test proved to be just as reliable as more invasive and costly tests at detecting Alzheimer’s and may even be able to detect the disease as long as 20 years prior to symptoms.  This is an exciting new development that could make detecting the disease much easier and speed up enrollment in clinical trials.

Leave a comment

Filed under Uncategorized

New blood test shows great promise in the diagnosis of Alzheimer’s disease

A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published in the Journal of the American Medical Association (JAMA) and simultaneously presented at the Alzheimer’s Association International Conference.

photo of head bust print artwork

Photo by meo on Pexels.com

For many years, the diagnosis of Alzheimer’s has been based on the characterization of amyloid plaques and tau tangles in the brain, typically after a person dies. An inexpensive and widely available blood test for the presence of plaques and tangles would have a profound impact on Alzheimer’s research and care. According to the new study, measurements of phospho-tau217 (p-tau217), one of the tau proteins found in tangles, could provide a relatively sensitive and accurate indicator of both plaques and tangles — corresponding to the diagnosis of Alzheimer’s — in living people. Continue reading

Leave a comment

Filed under Alzheimer's disease, Alzheimer's risk, Uncategorized

Memory loss reversed or abated in those with cognitive decline

Cognitive decline is a major concern of the aging population. Already, Alzheimer’s disease affects approximately 5.4 million Americans and 30 million people globally. Without effective prevention and treatment, the prospects for the future are bleak. By 2050, it is estimated that 160 million people globally will have the disease, including 13 million Americans, leading to potential bankruptcy of the Medicare system. Unlike several other chronic illnesses, Alzheimer’s disease is on the rise–recent estimates suggest that Alzheimer’s disease has become the third leading cause of death in the United States behind cardiovascular disease and cancer. Since its first description over 100 years ago, Alzheimer’s disease has been without effective treatment.

While researchers continue to seek out a cure, it is becoming clear that there are effective treatment options. More and more research supports the conclusion that Alzheimer’s disease is not a disease of only Beta Amyloid plaques and Tao tangles but a complex and systemic disease. In this study of patients with varying levels of cognitive decline, it is demonstrated how a precision and personalized approach results in either stabilization or improvement in memory.

239082_web.jpg

Affirmativ Health sought to determine whether a comprehensive and personalized program, designed to mitigate risk factors of Alzheimer’s disease could improve cognitive and metabolic function in individuals experiencing cognitive decline. Findings provided evidence that this approach can improve risk factor scores and stabilize cognitive function.

Continue reading

1 Comment

Filed under aging brain, Alzheimer's disease, Alzheimer's risk, brain, brain function, brain health

Scientists study the link between the gut and Alzheimer’s disease

Do you know that feeling you get in your gut? It turns out your gut may really be trying to tell you something.  Our microbiome – the 100 trillion bacteria and organisms living in our gut – appears to have a profound influence on our health and risk of disease. And early scientific studies show there may be a link between the microbiome and the brain that could impact the risk of Alzheimer’s and other brain diseases.

The microbiome is a collection of bacteria, viruses and fungi that live mostly in our intestinal system. They play an important role in digestion and the production of certain vitamins, and they support our immune system. Researchers around the world study the gut microbiome, especially those bacteria unique to individuals, to learn more about their influence on our overall health.

5 Comments

Filed under aging brain, Alzheimer's disease, Alzheimer's risk, brain, brain function, gut bacteria, gut health, gut microbes

“Love hormone” oxytocin could be used to treat cognitive disorders like Alzheimer’s

Alzheimer’s disease is a progressive disorder in which the nerve cells (neurons) in a person’s brain and the connections among them degenerate slowly, causing severe memory loss, intellectual deficiencies, and deterioration in motor skills and communication. One of the main causes of Alzheimer’s is the accumulation of a protein called amyloid β (Aβ) in clusters around neurons in the brain, which hampers their activity and triggers their degeneration.

Tokyo University of Science illustration

Studies in animal models have found that increasing the aggregation of Aβ in the hippocampus–the brain’s main learning and memory center–causes a decline in the signal transmission potential of the neurons therein. This degeneration affects a specific trait of the neurons, called “synaptic plasticity,” which is the ability of synapses (the site of signal exchange between neurons) to adapt to an increase or decrease in signaling activity over time. Synaptic plasticity is crucial to the development of learning and cognitive functions in the hippocampus. Thus, Aβ and its role in causing cognitive memory and deficits have been the focus of most research aimed at finding treatments for Alzheimer’s.

Leave a comment

Filed under Alzheimer's disease, Alzheimer's risk, cognition, cognitive decline, cognitive impairment, oxytocin